BLRX Annual CAPEX
$297.00 K
-$19.00 K-6.01%
31 December 2023
Summary:
As of January 23, 2025, BLRX annual capital expenditures is $297.00 thousand, with the most recent change of -$19.00 thousand (-6.01%) on December 31, 2023. BLRX annual CAPEX is now -97.09% below its all-time high of $10.22 million, reached on December 31, 2018.BLRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX Quarterly CAPEX
$0.00
-$27.00 K-100.00%
01 September 2024
Summary:
As of January 23, 2025, BLRX quarterly capital expenditures is $0.00, with the most recent change of -$27.00 thousand (-100.00%) on September 1, 2024. Over the past year, it has dropped by -$27.00 thousand (-100.00%). BLRX quarterly CAPEX is now -100.00% below its all-time high of $10.10 million, reached on December 31, 2018.BLRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX TTM CAPEX
$77.00 K
-$27.00 K-25.96%
01 September 2024
Summary:
As of January 23, 2025, BLRX TTM capital expenditures is $77.00 thousand, with the most recent change of -$27.00 thousand (-25.96%) on September 1, 2024. Over the past year, it has dropped by -$430.00 thousand (-84.81%). BLRX TTM CAPEX is now -99.25% below its all-time high of $10.22 million, reached on December 31, 2018.BLRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.0% | -100.0% | -84.8% |
| 3 y3 years | - | +100.0% | +126.5% |
| 5 y5 years | -97.1% | +100.0% | +126.5% |
BLRX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.0% | +206.2% | -100.0% | -84.8% | at low | |
| 5 y | 5-year | -6.0% | +306.9% | -100.0% | +100.0% | -84.8% | |
| alltime | all time | -97.1% | +440.0% | -100.0% | +100.0% | -99.3% |
BioLineRx CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $77.00 K(-26.0%) |
| June 2024 | - | $27.00 K(-15.6%) | $104.00 K(-48.0%) |
| Mar 2024 | - | $32.00 K(+77.8%) | $200.00 K(-32.7%) |
| Dec 2023 | $297.00 K(-6.0%) | $18.00 K(-33.3%) | $297.00 K(-41.4%) |
| Sept 2023 | - | $27.00 K(-78.0%) | $507.00 K(+0.2%) |
| June 2023 | - | $123.00 K(-4.7%) | $506.00 K(+18.5%) |
| Mar 2023 | - | $129.00 K(-43.4%) | $427.00 K(+35.1%) |
| Dec 2022 | $316.00 K(+225.8%) | $228.00 K(+776.9%) | $316.00 K(+110.7%) |
| Sept 2022 | - | $26.00 K(-40.9%) | $150.00 K(+24.0%) |
| June 2022 | - | $44.00 K(+144.4%) | $121.00 K(+26.0%) |
| Mar 2022 | - | $18.00 K(-71.0%) | $96.00 K(-1.0%) |
| Dec 2021 | $97.00 K(+32.9%) | $62.00 K(-2166.7%) | $97.00 K(+185.3%) |
| Sept 2021 | - | -$3000.00(-115.8%) | $34.00 K(-8.1%) |
| June 2021 | - | $19.00 K(0.0%) | $37.00 K(+94.7%) |
| Mar 2021 | - | $19.00 K(-2000.0%) | $19.00 K(>+9900.0%) |
| Dec 2020 | - | -$1000.00(<-9900.0%) | $0.00(-100.0%) |
| Sept 2020 | - | $0.00(-100.0%) | $20.00 K(-4.8%) |
| June 2020 | - | $1000.00(-94.7%) | $21.00 K(-71.2%) |
| Dec 2019 | $73.00 K(-99.3%) | $19.00 K(+1800.0%) | $73.00 K(-99.3%) |
| Sept 2019 | - | $1000.00(-95.5%) | $10.15 M(-0.0%) |
| June 2019 | - | $22.00 K(-29.0%) | $10.16 M(-0.1%) |
| Mar 2019 | - | $31.00 K(-99.7%) | $10.16 M(-0.5%) |
| Dec 2018 | $10.22 M(+141.1%) | $10.10 M(>+9900.0%) | $10.22 M(+1849.6%) |
| Sept 2018 | - | $3000.00(-90.0%) | $524.00 K(-3.0%) |
| June 2018 | - | $30.00 K(-63.9%) | $540.00 K(-3.2%) |
| Mar 2018 | - | $83.00 K(-79.7%) | $558.00 K(-86.8%) |
| Dec 2017 | $4.24 M | $408.00 K(+2047.4%) | $4.24 M(+14.6%) |
| Sept 2017 | - | $19.00 K(-60.4%) | $3.70 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $48.00 K(-98.7%) | $3.68 M(+0.2%) |
| Mar 2017 | - | $3.76 M(-2929.3%) | $3.67 M(+6572.7%) |
| Dec 2016 | $55.00 K(-98.0%) | -$133.00 K(<-9900.0%) | $55.00 K(-86.9%) |
| Sept 2016 | - | $0.00(-100.0%) | $419.00 K(-68.1%) |
| June 2016 | - | $40.00 K(-73.0%) | $1.31 M(-51.6%) |
| Mar 2016 | - | $148.00 K(-35.9%) | $2.72 M(-0.1%) |
| Dec 2015 | $2.72 M(+1308.8%) | $231.00 K(-74.2%) | $2.72 M(+7.8%) |
| Sept 2015 | - | $895.00 K(-37.9%) | $2.52 M(+48.8%) |
| June 2015 | - | $1.44 M(+855.0%) | $1.70 M(+470.7%) |
| Mar 2015 | - | $151.00 K(+344.1%) | $297.00 K(+53.9%) |
| Dec 2014 | $193.00 K(+65.0%) | $34.00 K(-50.0%) | $193.00 K(-0.6%) |
| Sept 2014 | - | $68.00 K(+54.5%) | $194.20 K(+29.3%) |
| June 2014 | - | $44.00 K(-6.4%) | $150.20 K(+4.1%) |
| Mar 2014 | - | $47.00 K(+33.5%) | $144.30 K(+23.3%) |
| Dec 2013 | $117.00 K(-33.7%) | $35.20 K(+46.7%) | $117.00 K(+2.2%) |
| Sept 2013 | - | $24.00 K(-37.0%) | $114.50 K(-4.1%) |
| June 2013 | - | $38.10 K(+93.4%) | $119.40 K(+34.3%) |
| Mar 2013 | - | $19.70 K(-39.8%) | $88.90 K(-49.6%) |
| Dec 2012 | $176.40 K(-38.1%) | $32.70 K(+13.1%) | $176.30 K(-12.8%) |
| Sept 2012 | - | $28.90 K(+280.3%) | $202.20 K(-4.6%) |
| June 2012 | - | $7600.00(-92.9%) | $212.00 K(-29.8%) |
| Mar 2012 | - | $107.10 K(+82.8%) | $302.00 K(+6.0%) |
| Dec 2011 | $284.80 K(-56.9%) | $58.60 K(+51.4%) | $284.80 K(-43.4%) |
| Sept 2011 | - | $38.70 K(-60.3%) | $503.30 K(+1.5%) |
| June 2011 | - | $97.60 K(+8.6%) | $495.70 K(+24.5%) |
| Mar 2011 | - | $89.90 K(-67.6%) | $398.10 K(+29.2%) |
| Dec 2010 | $660.90 K | $277.10 K(+791.0%) | $308.20 K(+891.0%) |
| Sept 2010 | - | $31.10 K | $31.10 K |
FAQ
- What is BioLineRx annual capital expenditures?
- What is the all time high annual CAPEX for BioLineRx?
- What is BioLineRx annual CAPEX year-on-year change?
- What is BioLineRx quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BioLineRx?
- What is BioLineRx quarterly CAPEX year-on-year change?
- What is BioLineRx TTM capital expenditures?
- What is the all time high TTM CAPEX for BioLineRx?
- What is BioLineRx TTM CAPEX year-on-year change?
What is BioLineRx annual capital expenditures?
The current annual CAPEX of BLRX is $297.00 K
What is the all time high annual CAPEX for BioLineRx?
BioLineRx all-time high annual capital expenditures is $10.22 M
What is BioLineRx annual CAPEX year-on-year change?
Over the past year, BLRX annual capital expenditures has changed by -$19.00 K (-6.01%)
What is BioLineRx quarterly capital expenditures?
The current quarterly CAPEX of BLRX is $0.00
What is the all time high quarterly CAPEX for BioLineRx?
BioLineRx all-time high quarterly capital expenditures is $10.10 M
What is BioLineRx quarterly CAPEX year-on-year change?
Over the past year, BLRX quarterly capital expenditures has changed by -$27.00 K (-100.00%)
What is BioLineRx TTM capital expenditures?
The current TTM CAPEX of BLRX is $77.00 K
What is the all time high TTM CAPEX for BioLineRx?
BioLineRx all-time high TTM capital expenditures is $10.22 M
What is BioLineRx TTM CAPEX year-on-year change?
Over the past year, BLRX TTM capital expenditures has changed by -$430.00 K (-84.81%)